BSX vs MDT
BSX and MDT side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | MDTMedtronic plc |
|---|---|---|
| Market cap | $64.26B | $127.02B |
| P/E (TTM) | 18.7 | 24.5 |
| P/B | 2.51 | 2.53 |
| P/S | 3.1x | 3.4x |
| Dividend yield | — | 2.86% |
| Revenue | $21.07B(TTM) | $37.54B(TTM) |
| Revenue growth (YoY) | 19.9% | 8.4% |
| Net income | $3.49B(TTM) | $430.00M(TTM) |
| Earnings growth (YoY) | 56.7% | 3.0% |
| EPS, diluted | $2.37(TTM) | $4.06(TTM) |
| EBIT margin | 18.0% | 17.8% |
| ROE | 11.3% | 0.0% |
| ROIC | 10.0% | 7.0% |
| Piotroski F | 8/9 | 8/9 |
| 1y total return | -56.8% | +10.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BSX vs MDT
| Metric | BSX | MDT |
|---|---|---|
| End value | $19.0K | $14.7K |
| Total return | +89.6% | +47.3% |
| CAGR | +6.4% | +3.8% |
| Volatility | 27.6% | 23.4% |
| Sharpe | 0.21 | 0.10 |
| Sortino | 0.29 | 0.14 |
| Max drawdown | -61.5% | -45.3% |
Based on 2600 common trading days, 2016-06-30 → 2026-11-02 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)